Once again this year, we asked our readers to weigh in on which company deserves the title of Medtech Company of the Year. We received nearly 900 responses, and the clear winner was Covidien, capturing almost one-third of the vote.

Voters were understandably impressed by the company’s pending merger with Medtronic, arguably the biggest move by device makers all year.

“Covidien’s proactive attitude demonstrates that it understands the shifting landscape in the medtech world,” one reader wrote.
Others were swayed by the company’s foray into wearables. “The Zephyr acquisition proved that Covidien has the vision and agility to execute on the promise of digital health,” another reader wrote.

And many cited the company’s continued ability to innovate.“Covidien’s focus on innovation—both organic and through strategic acquisitions—is very impressive,” wrote one.

With almost 20% of the vote, Exact Sciences took second place. “Cologuard offers a quantum leap in colorectal cancer screening,” wrote one reader.

Finally, Qualcomm just barely edged out CardioMEMS to take third place, with just under 17% of the vote.

“Qualcomm is innovating across the spectrum of medical tech—providing the technology that will allow aggregation of data from disparate biometric devices is especially powerful,” one reader commented. 

—Jamie Hartford, managing editor, MD+DI

[image courtesy of NIROTS/FREEDIGITALPHOTOS.NET]